According to modelling research presented by Beate Sander, University of Toronto, Canada, a stockpile of Tamiflu sufficient to cover 65% of a countrys population could cut deaths by approximately half. Treatment with the oral antiviral Tamiflu (oseltamivir) and prophylaxis for people exposed to infected patients could be one of the most cost-effective strategies for reducing illness and death during an influenza pandemic.

The reality is that country stockpiles of Tamiflu are limited and are targeted at treatment only rather than treatment and prevention.2 However, some governments are now planning for sufficient antiviral stockpiles that will allow them to provide Tamiflu preventatively to close contacts of infected individuals.

The disease modelling research analysed for the first time the cost-effectiveness of strategies to reduce the spread of pandemic influenza using Tamiflu prophylactically. It was predicted that this preventative approach is likely to be more cost-effective than treating symptomatic patients alone and may be an effective and cost-saving measure for reducing the impact of pandemic influenza.

This research is supported by an earlier analysis that indicates that a prevention strategy using Tamiflu may help contain a pandemic outbreak.

The study also predicts that if the stockpile is increased so that there is an unlimited supply of Tamiflu for treating symptomatic patients and for preventing infection in people exposed to these patients (household contacts and school/work contacts), illness attack rates and deaths could potentially be reduced by more than half when compared to no intervention.

This equates to a cost saving of 70,000 dollar per 1,000 population which would save 21 billion dollar in the US alone versus no intervention. Adding other strategies such as school closures further reduces the attack and death rate and provides a health benefit at a reasonable cost. The resear
'"/>




Page: 1 2
Related medicine news :

1. Viral encephalitis can cause more damage than already known
2. Gene-Nanoparticle Gene Transfer Is Better Than Viral Vector Transfer System
3. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
4. Possible Viral Cause Of Kawasaki Disease Identified
5. Viral Infection At Birth Leads To Cerebral Palsy.
6. African Viral Fever Hits Two TN Districts
7. Viral Haemorrhagic Septicaemia Attack On Farmed Trout
8. Spread of New Viral Fever Reported in Five States
9. Viral Epidemic In Gujarat
10. Kerala Tourism Affected by Viral Fever Outbreak
11. A New Viral Infection Causes Death Of A Baby In Britain